Cinnamyl caffeate Inhibitor

Name: Cinnamyl caffeate Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5762076
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5762076

Cinnamyl caffeate has cardiovascular protective effects, it can increase H9c2 cellular antioxidant potential, decrease intracellular calcium ion ([Ca2+]i) level, and prevent cell apoptosis; it possesses potent antiproliferative activity with the EC(50) value… More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Cinnamyl caffeate, Inhibitor

Full Product Name

Cinnamyl caffeate

Form/Format

Solid. Powder

Purity/Purification

98.00%

Preparation and Storage

Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent

Molecular Weight

296.31

Solubility

<1mg/ml refers to the product slightly soluble or insoluble

Formula

C18H16O4

CAS Number

115610-32-7

Target & IC50

Calcium Channel
NO

Product Categories/Family for Cinnamyl caffeate, inhibitor

Membrane transporter/Ion channel; Calcium Channel

Product References and Citations for Cinnamyl caffeate, inhibitor

Potential Protective Effects of Bioactive Constituents from Chinese Propolis against Acute Oxidative Stress Induced by Hydrogen Peroxide in Cardiac H9c2 Cells. Evid Based Complement Alternat Med. 2017;2017:7074147

Other Notes

Small volumes of Cinnamyl caffeate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Cinnamyl caffeate purchase

MBS5762076 is an inhibitor targeting Cinnamyl caffeate.